Navigation Links
Marburg haemorrhagic fever in Angola update

e. Rapid detection and isolation of patients, tracing and management of their close contacts, infection control in hospitals and protective clothing for staff work to interrupt chains of transmission and thus seal off opportunities for further spread.

Such straightforward measures are complicated by the distinct features of this disease. The sudden onset, dramatic symptoms, and rapid deterioration of patients, and the absence of a vaccine and effective treatment, invariably incite great anxiety in affected populations. This anxiety, in turn, can interfere with control operations, especially when communities begin hiding cases and bodies because of suspicions about the safety of hospitals.

In the current outbreak, such suspicions are understandable. Very few patients with laboratory-confirmed Marburg haemorrhagic fever have survived; most hospitalized patients have died within a day or two following admission. For affected communities, staff from the mobile teams, fully suited in protective gear, are seen as taking away relatives and loved ones who may never again be seen alive.

WHO staff in Uige have today reported further signs that community attitudes are improving, though hostility towards the mobile teams remains of concern in one area known to have recent cases and deaths. Efforts to sensitize affected communities are continuing, with local volunteers supported by Portuguese-speaking experts from Brazil and Mozambique.

Conditions in Angola ?a country weakened by almost three decades of civil unrest ?have presented additional challenges. Supplies of water and electricity are intermittent, also in health care facilities. Weakened infrastructures, including those for communications and transportation, are another problem. Yesterday, the WHO office in Uige was informed of a death in another municipality, but was unable to collect the body for safe burial because of poor road conditions.

Fortunately, spread of the disease beyo
'"/>

Source:WHO


Page: 1 2 3

Related biology news :

1. Marburg virus disease in Angola - update
2. WHO suspends Marburg work, appeals for new funds
3. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
4. Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease
5. Fragment of yellow fever virus may hold key to safer vaccine
6. Infectious disease expert warns of spread of Rocky Mountain spotted fever
7. Computer models aid understanding of antibody-dependent enhancement in spread of dengue fever
8. Typhoid fever led to the fall of Athens
9. Molecular mechanism may explain how fevers spark seizures
10. Genetically engineered mosquitoes show resistance to dengue fever virus
11. Worms produce surprise insight into human fever

Post Your Comments:
(Date:11/23/2009)... , , , , , , , ...Marshall, from the Environment Department at the U...yongia magomberae and his wider work in Tanzania....ion. , , , , , , , ... , , , A new species of chameleon has bee...
(Date:11/23/2009)...ix-week-old turkey poults could save millions of m...according to Dr. Gerald Steiner from the Dresden U...heir use of infrared spectroscopy to determine the... accurate method with the potential to be used by ...e eggs for breeding. The pilot study has just been...
(Date:11/23/2009)...l irritants such as air pollution and cigarette sm...oday in the American Journal of Respiratory and C...from Imperial College London and the University of...gs that can trigger coughing when a person is expo...st that their findings may ultimately lead to the ...
Breaking Biology News(10 mins):New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Rescuing male turkey chicks 2Research reveals exactly how coughing is triggered by environmental irritants 2Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 1Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 2Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 3Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 4Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 5Vision Pharma Is Granted Motion for Judgment 47885 1Vision Pharma Is Granted Motion for Judgment 47885 2Go Healthy Enters Letter of Intent to Acquire Premium Water Source 47883 1Go Healthy Enters Letter of Intent to Acquire Premium Water Source 47883 2
...ts need to be educated about managing fever in you...ly and often unnecessarily, according to a Queensl... QUT senior research fellow Anne Walsh conducted ...e childhood fever as part of her PhD. , Her resul...rics and Child Health. , Ms Walsh found that, of ...
.... 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) a l...ts, today announced that it has acquired a patent ...o secure portable locks. The company believes tha...ket. For many years, consumers have been using por...s, to secure personal belongings in lockers,and st...
...e a unique way of feeding reminiscent of a science...scovered. After seizing prey in its jaws, a second... forward into the mouth, grabs the food and carrie...s is really an amazing innovation for feeding beha...stdoctoral researcher in the Section of Evolution ...
Other Biology News:Fever causing headaches for Aussie parents 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2'Alien' jaws help moray eels feed 2
(Date:11/23/2009)...mensional carbon layer in which the carbon atoms a...oneycomb. Carbon nanotubes are rolled-up sheets of... graphite. Graphene boasts some very special chara...ellent thermal conductor, and reconciles such conf... addition, graphene is impermeable to gases, which...
(Date:11/23/2009)...c’s Sporicidin disinfectant solution and wip...fectants against H1N1 and Influenza A., , ...24, 2009 -- Contec Inc, the leading manufacturer o... Sporicidin disinfectants have been deemed by the... including Pandemic 2009 H1N1 influenza A virus (t...
(Date:11/23/2009)...23/PRNewswire/--PearlTherapeuticsInc.,abiopharmace...eatmentofchronicrespiratorydiseases,todayannounced...ectors.Mr.Rosenhas25yearsofexperienceinthepharmace...atGileadSciencesandALZACorporation.Hisappointmenti..., "Howiebringsawealthofproductdevelopment,comme...
(Date:11/20/2009)...PRNewswire/ -- Veridiam (www.veridiam.com) won the... category at the 2009 Workplace Excellence Awards.... for Human Resources Management and recognize inno...,, Veridiam was one of nine winners, selected f...nored at the recent awards ceremony. San Diego-bas...
Breaking Biology Technology:Polymer with honeycomb structure 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...NATICK, Mass. and MUNICH, Germany, Sept. 1 ,Boston...ced one-year data,from its landmark SYNTAX trial c...using the TAXUS(R) Express2(TM) Paclitaxel-Eluting...tery bypass graft (CABG) surgery. The,overall resu...erences,between PCI and CABG in rates of death or ...
...Four-month study detailing effects of treatment of...abs (ABL) ASAP 10 treatment indicates significant...r treatment; in-vitro laboratory work shows that ...irus into cells, "eventually destroying the virus"...rican Biotech Labs,developer of a new class of pro...
...GLENWOOD, Ill., Aug. 29 Landauer, Inc. (NYSE:,LDR...al radiation,monitoring, today announced the appoi...ts Board of Directors., Mr. Leatherman, currently...technology strategies and global contract negotiat...Chief Information Officer and,Executive Vice Presi...
Other Biology Technology:Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 5Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes 2Landauer, Inc. Appoints Two New Members to Board of Directors 2
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
...ector is specifically designed to target and displ...myces cerevisiae. Displayed proteins can be analyz...ative ligands. pYD1 uses the a-agglutinin yeast ad...1 and Aga2, to display recombinant protein on the ...
... series combines Harvard Apparatuss best pump mech...e range of configuration options. A lookup table i...ringes from all the major manufacturers. A bright,...information from across the lab. All models have R...
...rostaglandin F2α isopropyl ester (15(R)-17-... latanoprost-related isomer containing both a doub...yl group at C-15. Similar to 15(S)-latanoprost, 15...is a potential impurity in most commercial prepara...
Biology Products: